AUROPHARMA on the MoveAuropharma has started moving towards Wave 3 and 1st Target would be 1360 and this can go until 1470(Which you can try achieving using GTT, if you are fine to take a Risk). With upcoming budget, this would be a good bet.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
54.15INR
31.73 BINR
290.02 BINR
279.80 M
About AUROBINDO PHARMA
Sector
CEO
Kambam Nithyananda Reddy
Headquarters
Hyderabad
Website
Founded
1986
ISIN
INE406A01037
FIGI
BBG000BMFT44
Aurobindo Pharma Ltd. engages in the manufacturing of generic pharmaceuticals and active pharmaceutical ingredients. It operates under the following geographical segments: India, USA, Europe, and Rest of the World. Its portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics. The company was founded by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy on December 26, 1986 and is headquartered in Hyderabad, India.
Aurobindo pharma 23 July 2024If daily price close below channel trendline then it's tend to be bearish otherwise you can continue your upside ride until price touch upper fib sequence.
AUROBINDO PHARMA S/R for 10/7/24Support and Resistance Levels: In technical analysis, support and resistance levels are significant price levels where buying or selling interest tends to be strong. They are identified based on previous price levels where the price has shown a tendency to reverse or find support.
Support levels ar
AUROBINDO PHARMA S/R for 5/7/24Support and Resistance Levels: In technical analysis, support and resistance levels are significant price levels where buying or selling interest tends to be strong. They are identified based on previous price levels where the price has shown a tendency to reverse or find support.
Support levels ar
AUROPHARMA/SWING TRADE # STRONG CANDLE CLOSE
#TRADING WITHIN A PATTERN
# SL 1200
ALWAYS TAKE RISK REWARDS INTO ACCOUNT. IT IS THE CORE STRENGTH OF TRADING.
NO MATTER WHAT END OF THE DAY WHAT YOU EARN - WHAT YOU LOSE =RETURNS
"Investing in the stock market involves balancing risk and reward. Higher potential returns
AUROPHARMA - Analysis as COVID news in pictureAs we have seen some Profit booking/selling across the board last week, possible reason could be
- FII getting ready for Holiday
- Covid news
Swing trade above 1106
Investor Buy zone Buy Zone 1072 to 976
Stop loss - Swing trade 1070, Investor 880 on day closing below this levels for minimum t
Review and plan for 27th May 2024Nifty future and banknifty future analysis and intraday plan in kannada.
This video is for information/education purpose only. you are 100% responsible for any actions you take by reading/viewing this post.
please consult your financial advisor before taking any action.
----Vinaykumar hiremath
book profit in Aurobindo Pharma or take short position?
After around 3 months, sell signal is showing on Aurobindo pharma. If not short, i think the stock holders should book profit, and if it goes up further for next couple of weeks, then definitely take a short position for gain of around 10%.
AuropharmaAuropharma NSE:AUROPHARMA Looking Good
Breakout done
short term pick
#auropharma
#Swingtrade
Aurobindo Pharma19/05/2024
Aurobindo Pharma on Monthly chart
CMP: 1202.4
Target:1450-1700
SL: 1100 or as per the ris k capacity
Information is only for study Purpose
See all ideas
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AUROPHARMA is 1,386.30 INR — it has increased by 1.75% in the past 24 hours. Watch AUROBINDO PHARMA LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange AUROBINDO PHARMA LTD. stocks are traded under the ticker AUROPHARMA.
AUROPHARMA stock has risen by 3.46% compared to the previous week, the month change is a 14.28% rise, over the last year AUROBINDO PHARMA LTD. has showed a 73.72% increase.
We've gathered analysts' opinions on AUROBINDO PHARMA LTD. future price: according to them, AUROPHARMA price has a max estimate of 1,500.00 INR and a min estimate of 980.00 INR. Watch AUROPHARMA chart and read a more detailed AUROBINDO PHARMA LTD. stock forecast: see what analysts think of AUROBINDO PHARMA LTD. and suggest that you do with its stocks.
AUROPHARMA reached its all-time high on Jul 15, 2024 with the price of 1,409.25 INR, and its all-time low was 40.15 INR and was reached on Nov 18, 2011. View more price dynamics on AUROPHARMA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AUROPHARMA stock is 2.15% volatile and has beta coefficient of 0.87. Track AUROBINDO PHARMA LTD. stock price on the chart and check out the list of the most volatile stocks — is AUROBINDO PHARMA LTD. there?
Today AUROBINDO PHARMA LTD. has the market capitalization of 798.28 B, it has increased by 1.49% over the last week.
Yes, you can track AUROBINDO PHARMA LTD. financials in yearly and quarterly reports right on TradingView.
AUROBINDO PHARMA LTD. is going to release the next earnings report on Aug 8, 2024. Keep track of upcoming events with our Earnings Calendar.
AUROPHARMA earnings for the last quarter are 15.51 INR per share, whereas the estimation was 15.61 INR resulting in a −0.62% surprise. The estimated earnings for the next quarter are 16.23 INR per share. See more details about AUROBINDO PHARMA LTD. earnings.
AUROBINDO PHARMA LTD. revenue for the last quarter amounts to 75.80 B INR, despite the estimated figure of 73.38 B INR. In the next quarter, revenue is expected to reach 76.11 B INR.
AUROPHARMA net income for the last quarter is 9.09 B INR, while the quarter before that showed 9.36 B INR of net income which accounts for −2.94% change. Track more AUROBINDO PHARMA LTD. financial stats to get the full picture.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AUROBINDO PHARMA LTD. EBITDA is 58.43 B INR, and current EBITDA margin is 20.15%. See more stats in AUROBINDO PHARMA LTD. financial statements.
Like other stocks, AUROPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AUROBINDO PHARMA LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AUROBINDO PHARMA LTD. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AUROBINDO PHARMA LTD. stock shows the strong buy signal. See more of AUROBINDO PHARMA LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.